Educational comparison diagram illustrating the macroscopic and microscopic changes in the human brain associated with Alzheimer’s disease (AD). The visual is divided into two sections: (a) Healthy state and (b) Alzheimer’s disease state. At the macroscopic level, cross-sectional brain illustrations highlight a normal cerebral cortex and hippocampus versus a diseased brain showing significant shrinkage of the cerebral cortex, severe shrinkage of the hippocampus, and enlarged ventricles. At the microscopic level, the diagram compares neuronal morphology. Healthy neurons are depicted with intact cell bodies and axons. In contrast, the AD neuron demonstrates classic hallmarks of neurodegeneration: internal accumulation of tau neurofibrillary tangles (NFTs) within the cell body and the external deposition of amyloid-beta (Aβ) plaques around the axon terminals. This illustration serves to teach the pathophysiology of AD, focusing on structural atrophy and the proteinopathy involved in dementia progression. Key educational concepts include neuroanatomy, neurodegenerative pathology, and the amyloid/tau hypothesis.

A composite medical comparison image demonstrating lung pathology across five experimental conditions: Healthy, Model (Acute Lung Injury), CEP DPIs, CEP gavage, and DXM (Dexamethasone). The top row contains macroscopic clinical photographs of whole lung tissue. The 'Healthy' lung is light pink and smooth, while the 'Model' lung shows significant dark red discoloration, bruising, and edema. Treatment groups (CEP and DXM) show macroscopic recovery towards a normal pink appearance. The bottom row presents corresponding histopathological sections stained with hematoxylin and eosin (H&E) at 100x magnification. The 'Healthy' section reveals clear, thin-walled alveolar sacs. In contrast, the 'Model' section shows severe alveolar architectural destruction, marked thickening of alveolar septa, and dense inflammatory cell infiltration. The treatment groups, particularly the Cepharanthine dry powder inhaler (CEP DPIs) and DXM, demonstrate significant histological attenuation of injury, characterized by reduced septal thickening and decreased leucocyte infiltration, illustrating the anti-inflammatory efficacy of these interventions in a model of chemical-induced lung injury.

This medical comparison chart consists of two anatomical diagrams (A and B) representing the human lungs in a coronal view. Diagram A illustrates the anatomical distribution of pulmonary artery thrombosis, while Diagram B shows the distribution of inflammatory lung lesions, likely in the context of COVID-19. Both diagrams divide the lungs into five regions: the right superior, middle, and inferior lobes, and the left superior and inferior lobes. In Diagram A (Thrombosis), percentages range from 11% in the left superior lobe to 64% in the right inferior lobe. In Diagram B (Inflammation), percentages are significantly higher, ranging from 45% in the left superior lobe to 89% in the right inferior lobe. Both visualizations demonstrate a distinct predilection for the lower lobes compared to the upper and middle lobes. This anatomical mapping is intended to correlate the location of vascular complications with parenchymal inflammatory changes, highlighting the regional severity of pulmonary pathology.

A comparison grid of 129Xe Magnetic Resonance Imaging (MRI) parametic maps showing coronal slices of human lungs. The grid compares three subjects—a healthy never-smoker, a patient with Chronic Obstructive Pulmonary Disease (COPD), and a patient with Alpha-1 Antitrypsin Deficiency (AATD/COPD)—across three data acquisition methods: Fully Sampled, Acceleration Factor (AF) = 2, and AF = 3. Two quantitative parameters are visualized: Apparent Diffusion Coefficient (ADC) and Mean Linear Intercept (Lm). The ADC maps (scale 0 to 0.14 cm²/s) show a progression from uniform low values (red) in the healthy subject to higher, more heterogeneous values (yellow/white) in COPD and AATD, indicating increased gas diffusivity due to alveolar wall destruction (emphysema). The Lm maps (scale 100 to 900 μm) show a shift from predominantly low values (blue/cyan) in the healthy lung to elevated, heterogeneous values (green/red) in the diseased lungs, representing alveolar enlargement. The image demonstrates that undersampled reconstructions (AF 2 and 3) maintain high qualitative and quantitative fidelity compared to fully sampled data in assessing obstructive lung disease.

This diagnostic comparison presents four axial High-Resolution Computed Tomography (HRCT) lung windows, categorized by smoking history and anatomical level. Images A and B display the upper and lower lobes of an active smoker with the M/MProcida genotype. These images demonstrate significant structural lung damage, including centrilobular and paraseptal emphysema characterized by areas of low attenuation, architectural distortion, and bronchial wall thickening suggestive of bronchiectasis. Large bullae are particularly visible in the lower lobe periphery (Image B). In contrast, Images C and D display the upper and lower lobes of a never smoker with the M/I genotype. These scans show relatively preserved lung parenchyma with homogenous density and normal pulmonary vascular distribution, though minor areas of ground-glass opacity are present. The comparison highlights the severity of obstructive lung disease manifestations, specifically the progression of emphysematous changes and airway remodeling associated with chronic tobacco exposure in the context of Alpha-1 Antitrypsin Deficiency genetic variants. This material is suitable for medical education regarding radiology of Chronic Obstructive Pulmonary Disease (COPD).

High-resolution axial CT scans of the chest in a 48-year-old male smoker with COVID-19. Image (a) shows the upper lobes featuring marked centrilobular emphysema characterized by multiple lucent spaces centered on secondary pulmonary lobules. This is superimposed with patchy and subpleural ground-glass opacification (GGO), appearing as areas of hazy increased lung density. Image (b) shows the lower lobes, demonstrating peripheral ground-glass opacity in the right lower lobe with associated vascular thickening. The left lower lung shows architectural distortion with visible fibrous stripes and reticular markings. These findings represent a combination of chronic obstructive pulmonary disease (COPD) from smoking history and acute pulmonary manifestations consistent with viral pneumonia (COVID-19), illustrating how pre-existing emphysema can complicate the presentation of infectious lung disease.

This diagnostic image is an axial non-contrast-enhanced CT scan of the chest at the level of the upper lobes, demonstrating significant chronic obstructive pulmonary disease (COPD) pathology. The lung parenchyma shows extensive centrilobular emphysema, characterized by multiple small, focal areas of low attenuation representing alveolar destruction within the secondary pulmonary lobules. Complementary paraseptal emphysematous changes are visible as subpleural lucencies along the peripheral lung margins. In the apicoposterior segment of the left upper lobe, there is a localized area of increased attenuation consistent with a fibrotic lesion or reticular opacity. The distribution is primarily bilateral and upper-lobe predominant, which is characteristic of smoking-related lung disease. Key educational concepts include the radiographic differentiation between centrilobular and paraseptal emphysema and the identification of concurrent interstitial lung changes in a patient with multi-faceted parenchymal disease.

Clinical photograph showing a series of three respiratory physiotherapy interventions (labeled A, B, and C) for a patient in a hospital setting. Panel A depicts the forward-leaning position, with the patient seated and leaning over a supportive pillow to alleviate dyspnea by optimizing accessory muscle use. Panel B shows the patient in a semi-recumbent position performing diaphragmatic breathing exercises, indicated by the hand placement on the chest and abdomen to monitor breath depth and abdominal excursion. Panel C illustrates thoracic expansion exercises, with the patient seated and arms fully abducted and elevated to enhance chest wall mobility and lung volume. The environment includes standard medical equipment such as a wall-mounted cardiac monitor, bedside rails, and a medical professional assisting with the rehabilitation protocol. These interventions are typically used in post-operative or pulmonary rehabilitation contexts to address pleural effusion, atelectasis, and reduced respiratory capacity.

This clinical photograph illustrates a patient performing bedside pulmonary rehabilitation exercises within a hospital setting. The patient is seated upright on the edge of a hospital bed with hips and knees flexed at approximately 90 degrees. One arm is fully extended vertically toward the ceiling with the palm facing inward, demonstrating a thoracic expansion exercise designed to increase lung volume and improve respiratory mechanics. The background features a standard clinical environment, including an IV pole, a bedside table with medical supplies, and a hospital bed with a teal sheet. The photograph serves as an educational visual for physical therapy and cardiorespiratory rehabilitation protocols, specifically for managing extrapulmonary tuberculosis or chronic respiratory conditions. It highlights the integration of active limb movement with breathing techniques to enhance thoracic mobility and reduce dyspnea.

This clinical photograph captures a pediatric patient and a healthcare professional engaged in a respiratory physiotherapy session within a hospital setting. The patient, a young child, is shown in a long-sitting position on a hospital bed with legs extended. Guided by the therapist, the child is performing thoracic expansion exercises, characterized by the raising of both arms overhead with hands clasped to facilitate maximum lung volume and chest wall mobility. The healthcare professional, wearing a white clinical coat, stands adjacent to the bed and demonstrates the movement with their own arms extended and hands clasped. This intervention is typical for post-operative cardiac rehabilitation (following median sternotomy for VSD repair, as indicated by context) to prevent atelectasis and improve pulmonary function. The background reveals a standard clinical environment with a numbered patient station and safety-barred window. This image serves as an educational example of active-assisted breathing techniques and the role of physical therapy in pediatric cardiac recovery.